What is GRPN's health score?

Groupon, Inc. (GRPN) has a TradeApes health score of 46 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is GRPN's estimated fair value?

Based on our 5-year discounted cash flow model, Groupon, Inc.'s estimated fair value is $10.41 per share, representing a -62.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is GRPN undervalued or overvalued?

Our model currently rates GRPN as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

1 free score card remaining

Groupon, Inc. (GRPN)

Technology Overvalued low mixed

$27.83

Updated: 2026-07-18

TradeApes Score

Financial Strength

35 Weak

Operating Trend

60 Healthy

Relative Value

25 Stressed

Capital Allocation

50 Mixed

Risk Management

80 Strong

Est. Fair Value $10.41

DCF Upside -62.6%

Sector Rank #5690 of 15019

Key Findings

+ Strong FCF growth — free cash flow up more than 20% year over year

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

Industry Related Stocks

APPLIED OPTOELECTRONICS, INC. (AAOI) AAON, INC. (AAON) Apple Inc. (AAPL) Antiaging Quantum Living Inc. (AAQL) ABB LTD (ABBNY) ABB LTD (ABLZF)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.